-transparent.png){kind=logo}
The effects of cimetidine (single or repeated administration) on free unchanged captopril plasma levels, pharmacokinetic parameters and plasma converting enzyme inhibitory effects have been investigated in normal healthy volunteers. Cimetidine affected neither captopril pharmacokinetic parameters nor its biological effects, suggesting that no change in captopril dosing is necessary when cimetidine is co-administered.
Related Publications
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
November 1995,
International journal of clinical pharmacology and therapeutics,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
February 1998,
European journal of clinical pharmacology,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
December 1985,
Drug intelligence & clinical pharmacy,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
December 1982,
British journal of clinical pharmacology,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
September 2001,
Journal of clinical pharmacology,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
January 1979,
Hormone research,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
January 1992,
European journal of clinical pharmacology,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
April 2003,
Therapeutic drug monitoring,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
January 1995,
British journal of clinical pharmacology,
C Richer, and
M Bah, and
M Cadilhac, and
C Thuillez, and
J F Giudicelli
July 2002,
Epilepsia,
